e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical impact of irradiated lung volumetric modeling in adjuvant breast radiotherapy (RT)
A. Javia, S. Patel, R. Paliwal, P. Patel, D. Patel (Rajkot, Karamsad, India)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session:
Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session type:
Thematic Poster Session
Number:
708
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Javia, S. Patel, R. Paliwal, P. Patel, D. Patel (Rajkot, Karamsad, India). Clinical impact of irradiated lung volumetric modeling in adjuvant breast radiotherapy (RT). Eur Respir J 2012; 40: Suppl. 56, 708
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
The big lung trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the radical radiotherapy setting
Source: Eur Respir J 2003; 22: Suppl. 45, 163s
Year: 2003
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002
Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: A prospective study
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Influence of dose of radiotherapy on quality of life in patients with non-small cell lung cancer treated by radiotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005
Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Optimal integration of chemo- and radiotherapy in small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006
Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001
Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009
Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT)
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Lung function evaluation in gemcitabine and concurrent radiotherapy treatment in nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 376s
Year: 2001
Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer?
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
Adjuvant and neoadjuvant therapy in nonsmall cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Clinical year in review
Year: 2006
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept